Raleigh, NC (PRWEB) July 31, 2013
Clinverse, Inc., a global technology and eclinical commerce network for clinical trials, announced today the addition of Bud Owen as Chief Financial Officer and Tony Click as Chief Technology Officer. Both Bud and Tony bring extensive experience in their respective fields and serve as strategic members of the management team for the company.
In his role as CFO, Bud leads all financial aspects of the company, including accounting, treasury, tax and human resources activities. He is a veteran senior finance executive who was most recently with Clinipace, Inc., a global CRO. Prior to Clinipace, Bud served as CFO at a number of global companies in the software, web services, media and chemical industries. During his career, he has been either a principal or an advisor in more than 40 M&A transactions with a total transaction value of $1.5 billion. Bud has a Master of Business Administration from Queens University (Canada) and is an Ernst & Young (Toronto) alumni.
As Chief Technology Officer, Tony is responsible for all technical and architectural aspects of Clinverse’s software and eclinical commerce network. He brings more than 20 years of experience developing customer software solutions across many industries including finance, insurance, publishing, telecom, construction and utilities. His specialties include systems with high throughput, computationally intensive and ‘Big Data’ requirements. Prior to joining Clinverse, Tony provided outsourced CTO services for early-stage startups and served as the VP of Enterprise Architecture at Merkle, a database analytics company. Tony also ran his own consulting firm for 11 years, which delivered architectural and project management services. He received a Bachelor of Science in Electrical Engineering from Virginia Tech and a Master of Business Administration from Duke University’s Fuqua School of Business.
"We look forward to leveraging Bud and Tony’s industry knowledge and expertise to continue to grow our lead in the area of financial lifecycle systems for the clinical trials industry," said Steve Ayala, Clinverse co-founder and president. "Their leadership and experience are critical to our success as we continue to expand globally and seek to provide our customers with exceptional financial process automation solutions that fill an important, yet unmet need in clinical trials."
About Clinverse, Inc.
Clinverse, Inc. is a global technology and financial services company that delivers highly secure, cloud-based financial management and payment solutions for the clinical trials industry. Founded in 2008 and headquartered in Raleigh, NC, the company delivers clinical financial solutions through the only truly collaborative and transparent financial management and payment platform. Used by leading BioPharma companies, Clinverse has developed ClinPay®, a fully-configurable, game-changing SaaS-based platform which manages tens of millions of dollars in financial transactions for thousands of global sites while supporting payments in 140 different currencies. For more information, please visit http://www.clinverse.com.